Company Filing History:
Years Active: 2014
Title: Innovations by Jennifer Ferguson
Introduction
Jennifer Ferguson is a notable inventor based in Manchester, GB. She has made significant contributions to the field of biotechnology, particularly in the area of genetic testing. Her work has implications for the detection of mutations in critical genes, which can aid in the diagnosis and treatment of various diseases.
Latest Patents
Jennifer holds a patent for a polynucleotide primer that is designed to detect specific mutations in the PIK3CA gene. This patent includes a polynucleotide comprising at least the final six nucleotides of designated primer sequences. The method she developed allows for the detection of mutations such as H1047R, H1047L, E542K, and E545K. The innovative approach combines ARMS primers with Scorpion primers, enhancing the accuracy of genetic testing.
Career Highlights
Jennifer is currently employed at Qiagen Manchester Limited, where she continues to advance her research and development efforts. Her work at Qiagen has positioned her as a key player in the biotechnology sector, contributing to the company's mission of improving healthcare through innovative solutions.
Collaborations
Jennifer has collaborated with notable colleagues, including Ruth Board and Paul Francis Ravetto. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of genetic research.
Conclusion
Jennifer Ferguson's contributions to biotechnology, particularly through her patent on polynucleotide primers, highlight her innovative spirit and dedication to advancing genetic testing. Her work not only enhances our understanding of genetic mutations but also plays a crucial role in improving patient outcomes.